|
Market Closed -
Nasdaq
21:00:00 28/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 22.01 USD | +0.59% |
|
+1.90% | -17.81% |
| 08-18 | Barclays Adjusts Price Target on Amphastar Pharmaceuticals to $23 From $20, Maintains Equalweight Rating | MT |
| 08-07 | Amphastar Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
Chart: Technical Analysis
Stock exchange
Nasdaq
AMPH 22.01 $
+0.59%
4.94M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| AMPH | 22.01USD | +0.59% | 4.94M $ | |
CBOE
| AMPH | 22.00USD | +0.64% | 220K $ | |
|
Tradegate
| 29A | 19.00EUR | +1.23% | 4.18K € | |
|
Boerse Muenchen
| 29A | 18.96EUR | +1.12% | 1.35K € | |
|
Deutsche Boerse AG
| 29A | 18.29EUR | -0.71% | 0 € | |
|
Börse Stuttgart
| 29A | 18.91EUR | +1.12% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 22.02 | 24.03 | 29.26 |
| Spread/Res. | -0.05% | -8.41% | -24.78% |
| Spread/Supp. | +6.95% | +30.47% | +30.47% |
| Support | 20.58 | 16.87 | 16.87 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AMPH Stock
- Charts Amphastar Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
